当前位置:首页 / 胃肠起搏联合双歧杆菌四联活菌片治疗功能性消化不良的临床疗效及对胃动力和血清胃肠功能相关指标的影响
| 更新时间:2026-11-20
|
胃肠起搏联合双歧杆菌四联活菌片治疗功能性消化不良的临床疗效及对胃动力和血清胃肠功能相关指标的影响
Clinical efficacy of gastrointestinal pacing combined with Bifidobacterium tetravaccine tablets in the treatment of functional dyspepsia and its effects on gastric motility and serum gastrointestinal function-related parameters

内科 页码:546-550

作者机构:靖江市中医院消化科,江苏省靖江市 214500

DOI:10.16121/j.cnki.cn45-1347/r.2026.05.06

  • 中文简介
  • 英文简介
  • 参考文献

目的 探讨胃肠起搏联合双歧杆菌四联活菌片治疗功能性消化不良(FD)的临床疗效及其对胃动力和血清胃肠功能相关指标的影响。方法 选取2022年3月至2024年3月靖江市中医院收治的108例FD患者作为研究对象,采用密封信封抽签法将其随机分为对照组(n=54)和观察组(n=54)。对照组予以双歧杆菌四联活菌片治疗,观察组在对照组基础上加用胃肠起搏治疗,两组均连续治疗4周。比较两组临床疗效、临床症状缓解时间、血清胃肠功能相关指标、胃动力指标及不良反应总发生率。结果 观察组总有效率为96.30%(52/54),高于对照组的79.63%(43/54)(P<0.05)。观察组腹痛、腹胀、食欲下降、反酸、嗳气缓解时间均短于对照组(均P<0.05)。治疗4周后,两组血清生长激素、乙酰胆碱酯酶、胃动素水平均较治疗前升高,血清胆囊收缩素水平均较治疗前降低,且观察组上述指标均优于对照组(均P<0.05)。治疗4周后,两组胃窦收缩频率、收缩振幅、运动指数均较治疗前升高,且观察组均高于对照组(均P<0.05)。两组不良反应总发生率分别为11.11%(6/54)和7.41%(4/54),差异无统计学意义(P>0.05)。结论 在双歧杆菌四联活菌片治疗基础上加用胃肠起搏可提升FD患者的临床疗效,并改善胃动力及血清胃肠功能相关指标,但其远期获益及在更广泛人群中的适用性仍需更大样本、更长随访周期的研究进一步验证。

Objective To investigate the clinical efficacy of gastrointestinal pacing combined with Bifidobacterium tetravaccine tablets in the treatment of functional dyspepsia (FD) and its effects on gastric motility and serum gastrointestinal function-related parameters. Methods A total of 108 patients with FD admitted to Jingjiang Hospital of Traditional Chinese Medicine from March 2022 to March 2024 were selected as study subjects and randomly divided into a control group (n=54) and an observation group (n=54) using the sealed envelope lottery method. The control group was treated with Bifidobacterium tetravaccine tablets, while the observation group received additional gastrointestinal pacing therapy on the basis of the control group. Both groups were treated continuously for 4 weeks. The clinical efficacy, time to symptom relief, serum gastrointestinal function-related parameters, gastric motility parameters, and total incidence of adverse reactions were compared between the two groups. Results The total effective rate in the observation group was 96.30% (52/54), which was higher than that in the control group (79.63% [43/54]) (P<0.05). The time to relief of abdominal pain, abdominal distension, decreased appetite, acid reflux, and belching in the observation group was shorter than that in the control group (all P<0.05). After 4 weeks of treatment, the serum levels of growth hormone, acetylcholinesterase, and motilin in both groups were increased compared with those before treatment, while the serum cholecystokinin level was decreased compared with that before treatment; moreover, the above parameters in the observation group were superior to those in the control group (all P<0.05). After 4 weeks of treatment, the antral contraction frequency, contraction amplitude, and motility index in both groups were increased compared with those before treatment, and all the above parameters in the observation group were higher than those in the control group (all P<0.05). The total incidence of adverse reactions in the two groups was 11.11% (6/54) and 7.41% (4/54), respectively, with no statistically significant difference (P>0.05). Conclusion The addition of gastrointestinal pacing to Bifidobacterium tetravaccine tablets can improve the clinical efficacy in FD patients and ameliorate gastric motility and serum gastrointestinal function-related parameters. However, its long-term benefits and applicability in broader populations still require further verification by studies with larger samples and longer follow-up periods.


    无

6

浏览量

0

下载量

0

CSCD

工具集